ACTIVE

Farmafyt

Financial year 2025 · Closed on 31/12/2025

Net result19,7 k €-46,1 %over 1 year
Gross margin272,7 k €+12,0 %over 1 year
Equity553 k €+3,7 %over 1 year
Workforce3,0 ETP+25,0 %over 1 year

Identity

Source · BCE/KBO

Farmafyt is a Public limited company incorporated in 2006. Its main activity is: Agents involved in the sale of food, beverages and tobacco. Its registered office is in Chaudfontaine. It employs on average 3,0 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0882.541.137
Incorporation
14/07/2006
Legal form
Public limited company
Registered office
Drève St-Lambert 22 box b
4052 Chaudfontaine · WallonieSee on map
Contributed capital
218 600,00 €
Latest accounts
31/12/2025
Average workforce
3,0 ETP
Joint committees (1)
  • 20700
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 19 filings

Trend over 13 financial years

20252024202320222021
Income statement
Gross margin272,7 k €243,5 k €197,8 k €161,3 k €107,6 k €
EBITDA42 k €64,5 k €55,9 k €-2,2 k €-36,1 k €
Operating result41,6 k €64,3 k €55,8 k €-2,6 k €-36,5 k €
Net result19,7 k €36,7 k €40,5 k €-8,4 k €-40,4 k €
Balance sheet
Equity553 k €533,2 k €496,5 k €456 k €464,5 k €
Total assets689,5 k €659,3 k €785,5 k €627,2 k €550,1 k €
Cash28,7 k €49,8 k €96,3 k €54 k €37,9 k €
Debts136,5 k €126,1 k €289 k €171,1 k €85,7 k €
Other
Workforce3,0 ETP2,4 ETP2,0 ETP2,1 ETP2,8 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 100 k€ and 250 k€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

3 active · 14 ended

Active mandates

FARMAFYT HEALTHCARE

Managing director · 0679.925.161

Represented by MIGNON Philippe

Active
NOSHAQ PARTNERS

Director · 0808.219.836

Represented by ROSA Laurence

Active
PHARMBIOSOL

Director · 0599.848.790

Represented by OLIVIER Sabine

Active

Ended mandates

FARMAFYT HEALTHCARE

Director · since 21 avril 2020 · until 21 avril 2026 · 0679.925.161

Represented by PHILIPPE MIGNON

Ended
FARMAFYT HEALTHCARE

Managing director · since 21 avril 2020 · until 21 avril 2026 · 0679.925.161

Represented by MIGNON PHILIPPE

Ended
NOSHAQ PARTNERS

Director · since 21 avril 2020 · until 21 avril 2026 · 0808.219.836

Represented by Sabine OLIVIER

Ended
NOSHAQ PARTNERS

Director · since 21 avril 2020 · 0808.219.836

Represented by Laurence ROSA

Ended

Other companies at this address

Drève St-Lambert 22 4052 Chaudfontaine
CompanyCBE no.
DERMASKIN● Bankrupt
0738.605.114
ENNEO● Active
0831.561.895
0679.925.161

Full financial information

Source · NBB
202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date26/06/202630/06/202527/06/202402/06/202325/04/202218/06/2021
General meeting10/06/202604/04/202510/05/202426/05/202319/04/202207/06/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for 7 days

Annual accounts filings

Source · NBB, 19 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202510/06/202626/06/2026FrenchPDF
Abridged model31/12/202404/04/202530/06/2025FrenchPDF
Abridged model31/12/202310/05/202427/06/2024FrenchPDF
Abridged model31/12/202226/05/202302/06/2023FrenchPDF
Abridged model31/12/202119/04/202225/04/2022FrenchPDF
Abridged model31/12/202007/06/202118/06/2021FrenchPDF
Abridged model31/12/201916/04/202006/05/2020FrenchPDF
Abridged model31/12/201823/05/201927/05/2019FrenchPDF
Abridged model31/12/201714/06/201821/06/2018FrenchPDF
Micro model31/12/201601/06/201707/07/2017DutchPDF
Abridged model31/12/201501/04/201625/04/2016DutchPDF
Abridged model31/12/201401/06/201505/08/2015DutchPDF
Abridged model31/12/201301/06/201410/06/2014DutchPDF
Abridged model31/12/201201/06/201313/06/2013DutchPDF
Abridged model31/12/201101/06/201219/06/2012DutchPDF
Abridged model31/12/201001/06/201107/06/2011DutchPDF
Abridged model31/12/200915/06/201008/07/2010DutchPDF
Abridged model31/12/200801/06/200925/06/2009DutchPDF
Abridged model31/12/200715/06/200801/07/2008DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 100 k€ and 250 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

3 active · 14 ended

Active mandates

FARMAFYT HEALTHCARE

Managing director · 0679.925.161

Represented by MIGNON Philippe

Active
NOSHAQ PARTNERS

Director · 0808.219.836

Represented by ROSA Laurence

Active
PHARMBIOSOL

Director · 0599.848.790

Represented by OLIVIER Sabine

Active

Ended mandates

FARMAFYT HEALTHCARE

Director · since 21 avril 2020 · until 21 avril 2026 · 0679.925.161

Represented by PHILIPPE MIGNON

Ended
FARMAFYT HEALTHCARE

Managing director · since 21 avril 2020 · until 21 avril 2026 · 0679.925.161

Represented by MIGNON PHILIPPE

Ended
NOSHAQ PARTNERS

Director · since 21 avril 2020 · until 21 avril 2026 · 0808.219.836

Represented by Sabine OLIVIER

Ended
NOSHAQ PARTNERS

Director · since 21 avril 2020 · 0808.219.836

Represented by Laurence ROSA

Ended

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Registered office24/12/2024
    SIEGE SOCIAL
    PDF
  • Mandates05/05/2020
    CAPITAL, ACTIONS - DEMISSIONS, NOMINATIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …) - MODIFICATION FORME JURIDIQUE
    PDF
  • Mandates06/08/2018
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates26/10/2017
    MAATSCHAPPELIJKE ZETEL - ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates08/08/2016
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Other26/07/2006
    RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 202519,7 k €↓
  2. 2024
    Annual accounts 202436,7 k €↓
  3. 2023
    Annual accounts 202340,5 k €↑
  4. 2022
    Annual accounts 2022-8,4 k €↑
  5. 2021
    Annual accounts 2021-40,4 k €↓
  6. 2020
    Annual accounts 20201,8 k €↓
  7. 2019
    Annual accounts 2019140 k €↑
  8. 2018
    Annual accounts 201878,8 k €↓
  9. 2017
    Annual accounts 2017109,4 k €↑
  10. 2010
    Annual accounts 20106,1 k €↓
  11. 2009
    Annual accounts 200947,8 k €↑
  12. 2008
    Annual accounts 200815,2 k €↑
  13. 2007
    Annual accounts 2007-56,4 k €
  14. 14/07/2006
    IncorporationPublic limited company